Shockwave Medical Inc. products

Predictably Safe - Safely modify calcium while significantly reducing the risk of complications to make procedures more predictable and efficient. Distinctly Intuitive - Simplify the treatment of calcium from the very first case via a unique MOA on an intuitive platform. Consistently Effective - Proven to achieve low residual stenosis across multiple vessel beds by disrupting superficial and deep calcium.

Quicker Cycle Time With 2x Faster Pulsing. 2X Faster Pulsing: Shockwave M5+ delivers the same amount of energy quicker with the same safety and efficacy profile as Shockwave M5.

Predictably Safe - Safely modify calcium while significantly reducing the risk of complications to make procedures more predictable and efficient. Distinctly Intuitive - Simplify the treatment of calcium from the very first case via a unique MOA on an intuitive platform. Consistently Effective - Proven to achieve low residual stenosis across multiple vessel beds by disrupting superficial and deep calcium.

Challenging Calcium Made Shockingly Easy. Address the Challenges of Calcium Without Compromising. Predictably Safe - Safely modify calcium while significantly reducing the risk of complications to make procedures more predictable and efficient. Distinctly Intuitive - Simplify the treatment of calcium from the very first case via a unique MOA on an intuitive platform. Consistently Effective - Proven to achieve low residual stenosis across multiple vessel beds by disrupting superficial and deep calcium.

Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™*  for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve regurgitation. Millions of patients worldwide with coronary artery disease who are not candidates for revascularization suffer from refractory angina despite receiving optimal medical therapy.